Related Experiment Videos

[Treatment of idiopathic vesico-ureteral reflux in children]

G Audry1, J Bruézière

  • 1Service de Chirurgie Viscérale Pédiatrique, Hôpital Trousseau, Paris.

Annales D'Urologie
|January 1, 1992
PubMed

Insights

Vesicoureteral reflux (VUR) in children can lead to kidney scarring. While some infants resolve VUR naturally, others require intervention to prevent pyelonephritis and preserve kidney function.

Area of Science:

  • Pediatric Urology
  • Nephrology

Context:

  • Vesicoureteral reflux (VUR) is a primary cause of pyelonephritis in children.
  • Renal parenchymal scars resulting from pyelonephritis are irreversible and can impede kidney growth.

Purpose:

  • To outline treatment strategies for pediatric VUR aimed at preventing renal scarring.
  • To compare the efficacy and risks of surgical versus endoscopic VUR correction.

Summary:

  • VUR may spontaneously resolve in 50% of infants under 2 years old, with antiseptic treatment recommended during this period.
  • For persistent VUR, surgical correction (e.g., Cohen's technique) offers high success rates (98%).
  • Endoscopic Teflon injection for VUR has lower reliability and carries risks like distant dissemination, ureteric stenosis, and bladder stones, leading to its reduced use.

Impact:

  • Effective management of VUR is crucial for preventing long-term kidney damage in children.
  • Understanding treatment outcomes guides clinical decisions in pediatric urology.
  • The findings highlight the importance of specific, prolonged treatment to preserve renal function.

Related Concept Videos